T0	Participants 70 94	moderate to severe COPD.
T1	Participants 366 418	in subjects with symptomatic moderate to severe COPD
T2	Participants 503 509	study.
T3	Participants 510 706	Subjects 40 years or older with cigarette smoking history ≥10 pack-years and with the diagnosis of COPD and post-bronchodilator FEV(1) ≥40 to ≤ 80% of predicted normal and FEV(1)/FVC of ≤0.70 were
T4	Participants 1580 1607	addition of FSC to subjects